The Enterprise Value as of December 2025 (TTM) for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) is 17.74B

According to Guangzhou Innogen Pharmaceutl Grp Co Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 17.74B. This represents a change of -3477.26% compared to the average of -525157000.00 of the last 4 quarters.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) Historical Enterprise Value (quarterly & annually)

How has 2591.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Guangzhou Innogen Pharmaceutl Grp Co Ltd over the last ten years is 23.69B. The current 17.74B Enterprise Value has changed 7.39% with respect to the historical average. Over the past ten years (40 quarters), 2591.HK's Enterprise Value was at its highest in in the May 2025 quarter at -525157000.00. The Enterprise Value was at its lowest in in the May 2025 quarter at -525157000.00.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Guangzhou Innogen Pharmaceutl Grp Co Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) Average Enterprise Value

How has 2591.HK Enterprise Value performed in the past?

The current Enterprise Value of Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) Enterprise Value vs. Peers

How is 2591.HK’s Enterprise Value compared to its peers?

Guangzhou Innogen Pharmaceutl Grp Co Ltd’s Enterprise Value is greater than Lepu Biopharma Co., Ltd. (10.08B), less than Nanjing Leads Biolabs Co Ltd (0), greater than Shanghai Haohai Biological Technology Co., Ltd. (7.21B), greater than Everest Medicines Limited (13.98B), greater than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (11.81B), greater than Keymed Biosciences Inc. (15.74B), greater than Alphamab Oncology (9.16B), greater than Sihuan Pharmaceutical Holdings Group Ltd. (8.93B), greater than HBM Holdings Limited (1.18B), greater than Ab&B Bio Tech Co Ltd. (13.95B),

Build a custom stock screener for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guangzhou Innogen Pharmaceutl Grp Co Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guangzhou Innogen Pharmaceutl Grp Co Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.